Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 23, 2024 -- The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in Diabetes, Obesity and Metabolism.
Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence among U.S. adults. The analysis included 5.3 million participants in the Behavioral Risk Factor Surveillance System (2012 to 2022).
The researchers found that the overall prevalence of diabetes increased significantly by 18.6 percent during the study period, across all sociodemographic groups. The prevalence was highest among non-Hispanic Black people (15.8 percent) and individuals aged 65 years and older (23.86 percent). Compared with non-Hispanic White individuals, odds were higher among Hispanic individuals (adjusted odds ratio [aOR], 1.60), non-Hispanic Asians (aOR, 1.67), and non-Hispanic Black individuals (aOR, 2.10). Men had a slightly higher prevalence than women (12.56 versus 11.56 percent). Prevalence was 56 percent higher among individuals with lower incomes. Individuals with obesity faced the highest prevalence -- 19.23 percent -- compared with individuals with normal weight.
"This study showed significant increases in diabetes prevalence across the United States from 2012 to 2022, aligning with previous research demonstrating rising trends nationally over recent decades," the authors write. "Persistently high and increasing prevalence underscores the alarming diabetes epidemic facing the United States."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
MONDAY, June 23, 2025 -- For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist...
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 -- For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and...
DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes
WEDNESDAY, June 18, 2025 -- The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.